Explore 3 Stock Ideas & Industry Insights Download Free Report

18889881171
Shopping Cart 0
countryflagUS
Login

Cannlabs Inc

Healthcare US CANL

0.0001USD
0.00(0%)

Last update at 2026-06-19T20:00:00Z

Day Range

0.00010.0001
LowHigh

52 Week Range

0.00010.0001
LowHigh

Fundamentals

  • Previous Close 0.0001
  • Market Cap0.05M
  • Volume100
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-3.99121M
  • Revenue TTM1.72M
  • Revenue Per Share TTM0.03
  • Gross Profit TTM 0.55M
  • Diluted EPS TTM-

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax 0.87M 0.71M 0.52M 0.80M -3.24268M
Minority interest - - - - -
Net income 0.87M 0.71M 0.52M 0.80M -1.58422M
Selling general administrative - - - - -
Selling and marketing expenses - - - - -
Gross profit 2.06M 1.70M 1.25M 1.45M 0.48M
Reconciled depreciation - - - - -
Ebit 0.87M 0.71M 0.52M 0.80M -3.19248M
Ebitda 0.88M 0.72M 0.53M 0.81M -2.96308M
Depreciation and amortization 0.00842M 0.00841M 0.00868M 0.00628M 0.23M
Non operating income net other - - - - -
Operating income 0.87M 0.71M 0.52M 0.80M -3.18766M
Other operating expenses 3.52M 2.47M 2.24M 1.69M 4.55M
Interest expense 0.00307M 0.00151M 0.00153M 0.00070M 0.05M
Tax provision - - - - -
Interest income - - - - -
Net interest income - - - - -
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 0.87M - - - -1.65847M
Total revenue 4.39M 3.18M 2.77M 2.50M 1.36M
Total operating expenses 1.19M 0.98M 0.72M 0.64M 3.67M
Cost of revenue 2.33M 1.48M 1.52M 1.05M 0.89M
Total other income expense net -0.00307M -0.00151M -0.00153M -0.00070M -0.05502M
Discontinued operations - - - - -
Net income from continuing ops - - - - -
Net income applicable to common shares - - - - -
Preferred stock and other adjustments - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Total assets 3.25M 2.98M 2.70M 2.19M 1.32M
Intangible assets - - - - 0.02M
Earning assets - - - - -
Other current assets - - - - 0.11M
Total liab 0.85M 0.79M 0.78M 0.33M 2.95M
Total stockholder equity 2.40M 2.19M 1.92M 1.86M 0.00079M
Deferred long term liab - - - - -
Other current liab - - - - -
Common stock 0.42M 0.42M 0.42M 0.42M 0.07M
Capital stock - - - - -
Retained earnings 2.64M 2.21M 1.96M 1.83M -1.60573M
Other liab - - - - -
Good will - - - - -
Other assets - - - - -
Cash 0.65M 0.54M 0.50M 0.35M 0.01M
Cash and equivalents - - - - -
Total current liabilities 0.10M 0.04M 0.03M 0.13M 1.51M
Current deferred revenue - - - - 0.12M
Net debt -0.65103M -0.53842M -0.49862M -0.35329M 1.88M
Short term debt - - - - 0.46M
Short long term debt - - - - -
Short long term debt total - - - - 1.89M
Other stockholder equity -0.66000M -0.43830M -0.46381M -0.38500M 6.69M
Property plant equipment - - - - -
Total current assets 2.30M 2.03M 1.79M 1.78M 0.26M
Long term investments - - - - -
Net tangible assets - - - - -
Short term investments - - - - -
Net receivables 0.76M 0.69M 0.54M 0.59M 0.14M
Long term debt - - - - -
Inventory 0.89M 0.80M 0.76M 0.84M -
Accounts payable 0.10M 0.04M 0.03M 0.13M 0.93M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - - - -5.14572M
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 0.63M 0.63M 0.57M 0.07M 0.04M
Deferred long term asset charges - - - - -
Non current assets total 0.95M 0.96M 0.91M 0.41M 1.06M
Capital lease obligations - - - - -
Long term debt total - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments - - - - -
Change to liabilities - - - - -
Total cashflows from investing activities - - - 0.11M -0.33407M
Net borrowings - - - - -
Total cash from financing activities -0.66000M -0.49359M -0.42540M -0.38500M 1.55M
Change to operating activities - - - - -
Net income 0.87M 0.71M 0.52M 0.80M -1.58422M
Change in cash 0.11M 0.04M 0.15M 0.34M -
Begin period cash flow 0.54M 0.50M 0.35M 0.01M 0.01M
End period cash flow 0.65M 0.54M 0.50M 0.35M 0.01M
Total cash from operating activities 0.77M 0.53M 0.57M 0.55M -1.25727M
Issuance of capital stock - - - - -
Depreciation 0.00842M 0.00841M 0.00868M 0.00628M 0.23M
Other cashflows from investing activities - - - - 0.00020M
Dividends paid - - - - -
Change to inventory -0.08406M -0.04519M 0.08M -0.02292M -
Change to account receivables -0.07808M -0.14892M 0.06M -0.38583M -0.14395M
Sale purchase of stock - -0.05529M -0.88921M -0.38500M -
Other cashflows from financing activities -0.66000M -0.43830M - 0.11M -0.33407M
Change to netincome - - - - -
Capital expenditures 0.00000M 0.00000M 0.00000M 0.00000M 0.36M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -0.10498M -0.18782M 0.04M -0.25924M 0.73M
Stock based compensation - - - - -
Other non cash items 0.12M 0.20M -0.02412M 0.27M -0.92523M
Free cash flow 0.77M 0.53M 0.57M 0.55M -1.61704M

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
CANL
Cannlabs Inc		 - -% 0.0001 - - 0.03 25.22 8.65 -3.7313
ZTS
Zoetis Inc		 -2.135 2.71% 76.58 40.18 30.96 10.67 17.60 11.27 26.18
MKKGY
Merck KGaA ADR		 -0.19 0.62% 30.56 21.25 14.93 3.10 2.14 3.60 12.98
MKGAF
MERCK Kommanditgesellschaft auf Aktien		 - -% 157.12 21.73 14.95 3.16 2.15 3.56 12.82
GALDY
GALDERMA GROUP AG		 -0.12 0.28% 42.82 74.21 41.67 8.64 5.55 9.15 42.22

Reports Covered

Stock Research & News

View All

Profile

CannLabs, Inc. provides cannabis testing laboratory services in the United States. Its testing services include potency testing, residual solvent analysis, microbiological testing, pesticide testing, heavy metals testing, nutrient analysis, terpenes analysis, shelf-life/stability studies, gene expression testing, and genotyping/phenotyping testing. The company also offers data/analytics and consulting, as well as education services. CannLabs, Inc. was incorporated in 2010 and is based in Denver, Colorado.

Cannlabs Inc

3888 East Mexico Avenue, Denver, CO, United States, 80210

  • 303-309-0105
  • Employees : 37

Key Executives

Name Title Year Born
Mr. Mark C. Mirken Chairman & CEO 1945
Mr. Michael Wempe Head of Consulting and Research Department NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.